Baxter International (BAX) Cash & Equivalents (2009 - 2026)

Baxter International (BAX) has 18 years of Cash & Equivalents data on file, last reported at $2.0 billion in Q1 2026.

• On a quarterly basis, Cash & Equivalents fell 12.07% year-over-year to $2.0 billion in Q1 2026; TTM through Mar 2026 was $2.0 billion, a 12.07% decrease from a year earlier, with the FY2025 full-year figure at $2.0 billion, up 11.68% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $2.0 billion, up from $2.0 billion in the prior quarter.
• Over the last five years, Cash & Equivalents for BAX reached as high as $5.7 billion in Q3 2023 and fell as low as $1.4 billion in Q3 2024.
• Historically, Cash & Equivalents has averaged $2.2 billion across 5 years, with a median of $1.8 billion in 2024.
• Across the five-year window, Cash & Equivalents soared 257.03% in 2023 and sank 75.16% in 2024, its largest moves.
• Year by year, Cash & Equivalents stood at $1.6 billion in 2022, then jumped by 89.88% to $3.1 billion in 2023, then tumbled by 42.69% to $1.8 billion in 2024, then rose by 11.68% to $2.0 billion in 2025, then grew by 2.39% to $2.0 billion in 2026.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $2.0 billion in Q1 2026, $2.0 billion in Q4 2025, and $1.7 billion in Q3 2025.